67 related articles for article (PubMed ID: 36252912)
1. miR-451a suppresses papillary thyroid cancer cell proliferation and invasion and facilitates apoptosis through targeting DCBLD2 and AKT1.
Tan J; Li C; Ren L; Zhu X; Hua F; Fu Y
Mol Cell Probes; 2022 Dec; 66():101863. PubMed ID: 36252912
[TBL] [Abstract][Full Text] [Related]
2. The HOTAIRM1/miR-107/TDG axis regulates papillary thyroid cancer cell proliferation and invasion.
Li D; Chai L; Yu X; Song Y; Zhu X; Fan S; Jiang W; Qiao T; Tong J; Liu S; Fan L; Lv Z
Cell Death Dis; 2020 Apr; 11(4):227. PubMed ID: 32269214
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-203 restrains epithelial-mesenchymal transition, invasion and migration of papillary thyroid cancer by downregulating AKT3.
You A; Fu L; Li Y; Li X; You B
Cell Cycle; 2020 May; 19(10):1105-1121. PubMed ID: 32308106
[TBL] [Abstract][Full Text] [Related]
4. Circ_0011373 promotes papillary thyroid carcinoma progression by regulating miR-1271/LRP6 axis.
Huang G; Mao L; Hu X
Hormones (Athens); 2023 Sep; 22(3):375-387. PubMed ID: 37378808
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-3653-3p inhibited papillary thyroid carcinoma progression by regulating CRIPTO-1.
Bai X; Xu Y; Liu Y
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):272-276. PubMed ID: 38279419
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-130a-3p impedes the progression of papillary thyroid carcinoma through downregulation of KPNB1 by targeting PSME3.
Wang Y; Xu J; Zhu X; Kuang H
Endocrine; 2023 Oct; 82(1):96-107. PubMed ID: 37166548
[TBL] [Abstract][Full Text] [Related]
7. Expression Levels of MicroRNA-300/BCL2L11 in Papillary Thyroid Cancer and Their Clinical Diagnostic Values.
Shen Y; Li X; Xie R; Chen Y; Hu X; Liu Y; Ma H
Eur Surg Res; 2023; 64(3):342-351. PubMed ID: 37231813
[TBL] [Abstract][Full Text] [Related]
8. miR-217 inhibits proliferation, migration, and invasion via targeting AKT3 in thyroid cancer.
Lin Y; Cheng K; Wang T; Xie Q; Chen M; Chen Q; Wen Q
Biomed Pharmacother; 2017 Nov; 95():1718-1724. PubMed ID: 28962076
[TBL] [Abstract][Full Text] [Related]
9. LncRNA HAGLROS contribute to papillary thyroid cancer progression by modulating miR-206/HMGA2 expression.
Zeng Z; Tang S; Chen L; Hou H; Liu Y; Li J
Aging (Albany NY); 2023 Dec; 15(24):14930-14944. PubMed ID: 38112616
[TBL] [Abstract][Full Text] [Related]
10. HOXD9/miR-451a/PSMB8 axis is implicated in the regulation of cell proliferation and metastasis via PI3K/AKT signaling pathway in human anaplastic thyroid carcinoma.
Zhong Y; Yu F; Yang L; Wang Y; Liu L; Jia C; Cai H; Yang J; Sheng S; Lv Z; Weng L; Wu B; Zhang X
J Transl Med; 2023 Nov; 21(1):817. PubMed ID: 37974228
[TBL] [Abstract][Full Text] [Related]
11. miRNA-106a directly targeting RARB associates with the expression of Na(+)/I(-) symporter in thyroid cancer by regulating MAPK signaling pathway.
Shen CT; Qiu ZL; Song HJ; Wei WJ; Luo QY
J Exp Clin Cancer Res; 2016 Jun; 35(1):101. PubMed ID: 27342319
[TBL] [Abstract][Full Text] [Related]
12. circRNA mannosidase alpha class 1A member 2 contributes to the proliferation and motility of papillary thyroid cancer cells through upregulating metadherin via absorbing microRNA-449a.
Feng Y; Yang X; Wang Y; Chi N; Yu J; Fu X
Anticancer Drugs; 2023 Jan; 34(1):44-56. PubMed ID: 36066401
[TBL] [Abstract][Full Text] [Related]
13. miR-451a suppresses the proliferation and migration of high-grade serous ovarian cancer by targeting RAB5A through the Ras/Raf/MEK/ERK pathway.
Liu S; Wang K; Zhao Z; Pang Y; Liu F; Wang P; Wang Z; Yang X
J Gene Med; 2024 Jan; 26(1):e3649. PubMed ID: 38282155
[TBL] [Abstract][Full Text] [Related]
14. Translocated HMGB3 is involved in papillary thyroid cancer progression by activating cytoplasmic TLR3 and transmembrane TREM1.
Zhao Y; Lv HJ; Deng XY; Chen P; Garstka MA; Shi BY; Fu J
Cell Cycle; 2023; 22(23-24):2584-2601. PubMed ID: 38197217
[TBL] [Abstract][Full Text] [Related]
15. PIWIL1 Promotes Malignant Progression of Papillary Thyroid Carcinoma by Inducing EVA1A Expression.
Liu L; Wu F; Zhang X; Li X
Curr Cancer Drug Targets; 2024; 24(2):192-203. PubMed ID: 37403394
[TBL] [Abstract][Full Text] [Related]
16. Functional analysis of ESM1 by shRNA-mediated knockdown of its expression in papillary thyroid cancer cells.
Xie L; He L; Zhang W; Wang H
PLoS One; 2024; 19(4):e0298631. PubMed ID: 38626010
[TBL] [Abstract][Full Text] [Related]
17. MiR-451a suppressing BAP31 can inhibit proliferation and increase apoptosis through inducing ER stress in colorectal cancer.
Xu K; Han B; Bai Y; Ma XY; Ji ZN; Xiong Y; Miao SK; Zhang YY; Zhou LM
Cell Death Dis; 2019 Feb; 10(3):152. PubMed ID: 30770794
[TBL] [Abstract][Full Text] [Related]
18. Clinical Impact of Androgen Receptor-Suppressing miR-146b Expression in Papillary Thyroid Cancer Aggressiveness.
Chou CK; Chi SY; Hung YY; Yang YC; Fu HC; Wang JH; Chen CC; Kang HY
J Clin Endocrinol Metab; 2023 Oct; 108(11):2852-2861. PubMed ID: 37220080
[TBL] [Abstract][Full Text] [Related]
19. YTHDC2 Retards Cell Proliferation and Triggers Apoptosis in Papillary Thyroid Cancer by Regulating CYLD-Mediated Inactivation of Akt Signaling.
Zhou G; Wang S
Appl Biochem Biotechnol; 2024 Jan; 196(1):588-603. PubMed ID: 37162682
[TBL] [Abstract][Full Text] [Related]
20. Network Pharmacological Analysis and Experimental Validation of the Effects of Silybin on Proliferation, Migration, and Immunotherapy of Papillary Thyroid Cancer.
Xie W; Li H; Lin Q; Ke N
Endocr Metab Immune Disord Drug Targets; 2024; 24(6):672-690. PubMed ID: 37855349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]